Literature DB >> 9349350

Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.

K Boeck1, S Hofmann, M Klopfer, U Ian, T Schmidt, R Engst, C E Thirkill, J Ring.   

Abstract

A 51-year-old white male suffering from metastatic malignant melanoma of the skin presented with lymph node metastases and paraneoplastic retinopathy 4 years after resection of the primary tumour. There were no cerebral metastases. Ocular symptoms consisting of night blindness and sensations of 'shimmering lights' persisted after total resection of the inguinal lymph node metastases and administration of dacarbazine and prednisone. Perimetry of both eyes was abnormal with concentric restriction. Electroretinography showed significantly reduced amplitudes in both eyes. Only 11 patients with melanoma-associated retinopathy (MAR) have been described. High titres of autoantibodies against whole retina extract were detected by enzyme-linked immunosorbent assay (ELISA) reactions. Indirect immunohistochemistry showed strong autoantibody activity against retinal bipolar cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349350

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.

Authors:  Eleni Karatsai; Anthony G Robson; Simon R J Taylor
Journal:  JAMA Ophthalmol       Date:  2019-05-01       Impact factor: 7.389

2.  Treatment of melanoma-associated retinopathy.

Authors:  Steven F Powell; Arkadiusz Z Dudek
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

3.  Cancer-associated retinopathy (CAR) with electronegative ERG: a case report.

Authors:  Griet Goetgebuer; Anna-Maria Kestelyn-Stevens; Jean-Jacques De Laey; Philippe Kestelyn; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2007-08-25       Impact factor: 2.379

4.  Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Authors:  Juliette Varin; Margaret M Reynolds; Nassima Bouzidi; Sarah Tick; Juliette Wohlschlegel; Ondine Becquart; Christelle Michiels; Olivier Dereure; Robert M Duvoisin; Catherine W Morgans; José-Alain Sahel; Quentin Samaran; Bernard Guillot; José S Pulido; Isabelle Audo; Christina Zeitz
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

5.  Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice.

Authors:  Wei-Hong Xiong; Robert M Duvoisin; Grazyna Adamus; Brett G Jeffrey; Celia Gellman; Catherine W Morgans
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

6.  Paraneoplastic retinopathy associated with occult bladder cancer.

Authors:  M Nivean; Danson V Muttuvelu; Pia Afzelius; Dalia C Berman
Journal:  Indian J Ophthalmol       Date:  2016-03       Impact factor: 1.848

Review 7.  Typical electronegative electroretinography and nyctalopia as a presenting feature of systemic malignant melanoma.

Authors:  Abby Vercio; K V Chalam; Timothy Winter
Journal:  Int Med Case Rep J       Date:  2019-08-13

8.  Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review.

Authors:  Jacob S Heng; Jenna M Kim; D Kyle Jones; Kathleen M Stoessel; Sarah A Weiss; Mario Sznol; Harriet M Kluger; Scott D Walter; Niki A Silverstein; Renelle Pointdujour-Lim
Journal:  BMJ Open Ophthalmol       Date:  2022-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.